Almost One in Four Skin Biopsies Is Melanocytic Proliferation

Share this content:
Almost One in Four Skin Biopsies Is Melanocytic Proliferation
Almost One in Four Skin Biopsies Is Melanocytic Proliferation

FRIDAY, Nov. 3, 2017 (HealthDay News) -- About one-quarter of skin biopsies are diagnosed as melanocytic proliferation, according to a study published online Nov. 1 in JAMA Dermatology.

Jason P. Lott, M.D., from Cornell Scott-Hill Health Center in New Haven, Connecticut, and colleagues examined the frequencies and distribution of histologically confirmed melanocytic lesions by conducting a natural language processing-based analysis of electronic medical record pathology reports of adult patients who underwent skin biopsies. The authors examined 80,368 skin biopsies performed on 47,529 patients.

The researchers found that 23 percent of skin biopsies were of melanocytic lesions. Based on the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis, 83.1, 8.3, 4.5, 2.2, and 1.9 percent of lesions were class I (nevi and other benign proliferations such as mildly dysplastic lesions usually requiring no further treatment), class II (moderately dysplastic and other low-risk lesions), class III (melanoma in situ and other higher-risk lesions), class IV, and class V (for class IV/V: invasive melanoma requiring wide re-excision and potential adjunctive therapy), respectively.

"Approximately one-quarter of skin biopsies resulted in diagnoses of melanocytic proliferations. These data provide the first population-based estimates across the spectrum of melanocytic lesions ranging from benign through dysplastic to malignant," the authors write. "These results may serve as a foundation for future research seeking to understand the epidemiology of melanocytic proliferations and optimization of skin biopsy utilization."

One author is an employee of Bayer US LLC.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »